Padmapriyadarsini, C.; Solanki, R.; Jeyakumar, S.M.; Bhatnagar, A.; Muthuvijaylaksmi, M.; Jeyadeepa, B.; Reddy, D.; Shah, P.; Sridhar, R.; Vohra, V.;
et al. Linezolid Pharmacokinetics and Its Association with Adverse Drug Reactions in Patients with Drug-Resistant Pulmonary Tuberculosis. Antibiotics 2023, 12, 714.
https://doi.org/10.3390/antibiotics12040714
AMA Style
Padmapriyadarsini C, Solanki R, Jeyakumar SM, Bhatnagar A, Muthuvijaylaksmi M, Jeyadeepa B, Reddy D, Shah P, Sridhar R, Vohra V,
et al. Linezolid Pharmacokinetics and Its Association with Adverse Drug Reactions in Patients with Drug-Resistant Pulmonary Tuberculosis. Antibiotics. 2023; 12(4):714.
https://doi.org/10.3390/antibiotics12040714
Chicago/Turabian Style
Padmapriyadarsini, Chandrasekaran, Rajesh Solanki, S. M. Jeyakumar, Anuj Bhatnagar, M. Muthuvijaylaksmi, Bharathi Jeyadeepa, Devarajulu Reddy, Prashanth Shah, Rathinam Sridhar, Vikram Vohra,
and et al. 2023. "Linezolid Pharmacokinetics and Its Association with Adverse Drug Reactions in Patients with Drug-Resistant Pulmonary Tuberculosis" Antibiotics 12, no. 4: 714.
https://doi.org/10.3390/antibiotics12040714
APA Style
Padmapriyadarsini, C., Solanki, R., Jeyakumar, S. M., Bhatnagar, A., Muthuvijaylaksmi, M., Jeyadeepa, B., Reddy, D., Shah, P., Sridhar, R., Vohra, V., & Bhui, N. K.
(2023). Linezolid Pharmacokinetics and Its Association with Adverse Drug Reactions in Patients with Drug-Resistant Pulmonary Tuberculosis. Antibiotics, 12(4), 714.
https://doi.org/10.3390/antibiotics12040714